SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (193)7/7/1997 7:51:00 PM
From: Ed Ajootian   of 10280
 
John,

Thanks, I had seen these. I also have found that the Dow did pick up
the story. For some reason Compuserve news (which carries Dow wires)
hiccupped and did not pick up the Dow story on SEPR.

IMO it is very bullish that this thing is knocking on the door to a new
all-time high a full week after putting out news that was so widely
expected. Looks like the Phase I/II Oxybutynin and/or the Phase II
Norastemizole studies are about to be unveiled.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News